Uromigos podcast launches a series with the pioneers of GU oncology
By Alexandria Carolan | Nov. 4, 2021
Brian Rini and Thomas Powles are documenting genitourinary oncology history in a new series on the Uromigos podcast.
“People don’t know the early stories,” Rini, chief of clinical trials, Ingram Professor of Medicine, and professor of medicine at Vanderbilt-Ingram Cancer Center, said to The Cancer Letter. “We’ll say, ‘Take us back to your early faculty days and what you were doing. How’d you get interested in GU cancer?’ Everybody has a really interesting route.”
In the Uromingos podcast, Rini and co-host Powles, professor of genitourinary oncology, lead for solid tumour research, and director of Barts Cancer Centre in London, focus on the latest developments in GU oncology.
So far, they have interviewed five GU oncologists about their early work and contributions to the field: Nick Vogelzang, Maha Hussain, Dean Bajorin, Phil Kantoff, and Larry Einhorn.
The Uromigos “Legends of GU Oncology” series is part of a growing number of podcasts focusing on cancer history, which also includes ASCO’s Your Stories: Conquering Cancer, and Cancer History Project editorial board member Daniel F. Hayes’ series on the Journal of Clinical Oncology’s Cancer Stories.
Spotlight article
Video: Norman D.Sharpless Calabresi Lecture, Nov. 2, 2021
By Yale | Nov. 5, 2021
Sharpless: Today in our age of rapid progress and technical and medical advances, it may be easy to discount the importance of the National Cancer Act. But as 1776 was our nation’s history, and 1969 was the Apollo program that put a human on the moon, 1971 really marks the modern era of cancer research. Maybe this comparison strikes you as a little bit over the top, but I do not believe that is so. Ending cancer as we know it will be as big of a deal for humanity as landing someone on the moon.
1971 is really what got us started. That’s why this anniversary is so important. It was signed into law at a time of great need for those people who feared cancer so much, which at the time was basically everyone. The NCA’s first 50 years was the work of people like Mary Lasker, optimistic politicians, and pioneering oncologists and researchers who were visionary, as I said, but also naïve, as I said.
Quote of the week
There is no mention of eradicating all cancer. Based on what we know about human biology today, we don’t believe that’s possible at the NCI, at least any time soon. But, we do think we can dramatically change the experience of cancer—that is, the tragedy of cancer, the way the American public knows cancer today.
Ned Sharpless
Lung cancer and tobacco control
- The National Cancer Act’s Effect on Tobacco Control: Success Endures, Challenges Remain
By ASCO | Nov. 3, 2021 - National Cancer Act and Lung Cancer Screening: An Example of Intended Impact
By ASCO | Nov. 2, 2021 - Decades-long partnership addresses tobacco use in African Americans
By The University of Kansas Cancer Center | Nov. 1, 2021
Recent contributions
- ATLAS continues pushing the envelope of surgical excellence while enhancing patient safety
By Roswell Park Comprehensive Cancer Center | Nov. 3, 2021 - Creating the Modern Cancer Center
By Fox Chase Cancer Center | Nov. 2, 2021
This column features the latest posts to the Cancer History Project by our growing list of contributors.
The Cancer History Project is a free, web-based, collaborative resource intended to mark the 50th anniversary of the National Cancer Act and designed to continue in perpetuity. The objective is to assemble a robust collection of historical documents and make them freely available.
Access to the Cancer History Project is open to the public at CancerHistoryProject.com. You can also follow us on Twitter at @CancerHistProj.
Is your institution a contributor to the Cancer History Project? Eligible institutions include cancer centers, advocacy groups, professional societies, pharmaceutical companies, and key organizations in oncology.
To apply to become a contributor, please contact admin@cancerhistoryproject.com.
